TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 184 filers reported holding TG THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.79 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $1,287,341 | -5.3% | 108,820 | +285.7% | 0.33% | -11.9% |
Q1 2021 | $1,360,000 | -18.5% | 28,211 | -12.0% | 0.38% | -16.6% |
Q4 2020 | $1,668,000 | -4.4% | 32,055 | -50.8% | 0.45% | -29.4% |
Q3 2020 | $1,744,000 | -6.8% | 65,182 | -32.1% | 0.64% | -23.9% |
Q2 2020 | $1,871,000 | – | 96,028 | – | 0.84% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 8,198,337 | $33,613,000 | 1.96% |
GREAT POINT PARTNERS LLC | 3,000,000 | $12,300,000 | 1.56% |
BRIDGER MANAGEMENT, LLC | 3,791,531 | $15,545,000 | 1.30% |
Avoro Capital Advisors LLC | 4,750,000 | $19,475,000 | 1.16% |
Opaleye Management Inc. | 550,000 | $2,255,000 | 0.84% |
CREDIT AGRICOLE S A | 1,307,428 | $5,360,000 | 0.30% |
Eversept Partners, LP | 65,000 | $266,500 | 0.14% |
HIGHLAND CAPITAL MANAGEMENT LP | 453,360 | $1,859,000 | 0.14% |
683 Capital Management, LLC | 500,000 | $2,050,000 | 0.12% |
Artal Group S.A. | 400,000 | $1,640,000 | 0.06% |